Atrial Fibrillation - A Common Ground for Neurology and Cardiology

Area of Science:

• Neurology
• Cardiology
• Neurovascular Medicine
• Cardiovascular Medicine

Background:

• Atrial fibrillation (AF) is a major cause of cardioembolic stroke, accounting for approximately 20% of all strokes.
• A significant unmet need exists for safer and more effective prophylactic agents for both primary and secondary stroke prevention in AF patients.

Purpose of the Study:

• To provide a comprehensive overview of atrial fibrillation (AF) from both neurological and cardiological perspectives.
• To examine the intricate relationship between neurovascular and cardiovascular diseases in the context of AF.
• To discuss risk factors, cognitive impact, and current prophylactic strategies for AF-related stroke.

Main Methods:

• Literature review and synthesis of existing research on atrial fibrillation, stroke, and related cardiovascular and neurological conditions.
• Analysis of the interplay between neurovascular and cardiovascular systems in AF.
• Evaluation of traditional and novel risk factors, cognitive implications, and existing medical and surgical interventions for embolism prophylaxis.

Main Results:

• Atrial fibrillation presents complex challenges at the intersection of neurology and cardiology.
• Understanding the dynamic interplay between neurovascular and cardiovascular factors is crucial for managing AF-related stroke risk.
• Current research highlights various risk factors, the impact of AF on cognitive function, and available prophylactic treatments.

Conclusions:

• Effective management of atrial fibrillation requires an integrated approach considering both neurological and cardiovascular aspects.
• Further research into novel prophylactic agents and treatment strategies is essential to mitigate the significant stroke burden associated with AF.
• Addressing AF-related cognitive decline and optimizing embolism prophylaxis are critical areas for clinical advancement.